![]()
|
|
||||||||
J. Biol. Chem., Vol. 269, Issue 4, 2541-2549, Jan, 1994
SA Thompson, S Higashiyama, K Wood, NS Pollitt, D Damm, G McEnroe, B Garrick, N Ashton, K Lau and N Hancock
Heparin-binding (HB) epidermal growth factor (EGF)-like growth factor
(HB-EGF), a member of the EGF protein family, is a potent mitogen for
fibroblasts, smooth muscle cells, and keratinocytes that was initially
identified as a secreted product of macrophage-like cells. HB-EGF and EGF
appear to act on target cells utilizing the same receptor, but HB- EGF is
distinguishable from EGF by its strong affinity for heparin. To facilitate
studies of structure-function relationships in HB-EGF, a bacterial
recombinant expression system was established that produced biologically
active HB-EGF with the expected disulfide bonding pattern. Mutagenesis and
protease digestion studies of the recombinant HB-EGF, coupled with
heparin-binding analyses of synthetic peptides, indicated that the
sequences within HB-EGF mediating its interaction with heparin are located
primarily in a stretch of 21 amino acids characterized by a high content of
lysine and arginine residues. Most of this heparin- binding domain lies in
an amino-terminal region of HB-EGF that has no counterpart in EGF, but a
portion of the 21-residue sequence extends into the EGF-like region of
HB-EGF. In addition, the mutagenesis and synthetic peptide studies
indicated that sequences in HB-EGF lying outside of the 21-residue stretch
can also influence the interaction with heparin. Finally, a synthetic
peptide derived from the 21-residue stretch was found to compete with
HB-EGF for binding to Chinese hamster ovary cells, suggesting that the
heparin-binding sequences in HB-EGF may also mediate the interaction of
this factor with cell surface heparan sulfate proteoglycan.
Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin
Scios Nova Inc., Mountain View, California 94043.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. Tokunou, R. Miller, P. Patwari, M. E. Davis, V. F. M. Segers, A. J. Grodzinsky, and R. T. Lee Engineering insulin-like growth factor-1 for local delivery FASEB J, June 1, 2008; 22(6): 1886 - 1893. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S Mummery, B. Mulloy, and C. C Rider The binding of human betacellulin to heparin, heparan sulfate and related polysaccharides Glycobiology, October 1, 2007; 17(10): 1094 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gooz, P. Gooz, L. M. Luttrell, and J. R. Raymond 5-HT2A Receptor Induces ERK Phosphorylation and Proliferation through ADAM-17 Tumor Necrosis Factor-{alpha}-converting Enzyme (TACE) Activation and Heparin-bound Epidermal Growth Factor-like Growth Factor (HB-EGF) Shedding in Mesangial Cells J. Biol. Chem., July 28, 2006; 281(30): 21004 - 21012. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Akayama, S. Takekida, N. Ohara, H. Tateiwa, W. Chen, K. Nakabayashi, and T. Maruo Gene expression and immunolocalization of heparin-binding epidermal growth factor-like growth factor and human epidermal growth factor receptors in human corpus luteum Hum. Reprod., October 1, 2005; 20(10): 2708 - 2714. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, N. Ohara, S. Takekida, Q. Xu, and T. Maruo Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells Hum. Reprod., June 1, 2005; 20(6): 1456 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Takazaki, Y. Shishido, R. Iwamoto, and E. Mekada Suppression of the Biological Activities of the Epidermal Growth Factor (EGF)-like Domain by the Heparin-binding Domain of Heparin-binding EGF-like Growth Factor J. Biol. Chem., November 5, 2004; 279(45): 47335 - 47343. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, C. B. Rich, J. A. Buczek-Thomas, M. A. Nugent, M. P. Panchenko, and J. A. Foster Heparin-binding EGF-like growth factor regulates elastin and FGF-2 expression in pulmonary fibroblasts Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L1106 - L1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tei, N. Kawakami-Kimura, O. Taguchi, K. Kumamoto, S. Higashiyama, N. Taniguchi, K.'i. Toda, R. Kawata, Y. Hisa, and R. Kannagi Roles of Cell Adhesion Molecules in Tumor Angiogenesis Induced by Cotransplantation of Cancer and Endothelial Cells to Nude Rats Cancer Res., November 1, 2002; 62(21): 6289 - 6296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Cha, J. S. Brooke, M. Y. Chang, and L. Eidels Receptor-Based Antidote for Diphtheria Infect. Immun., May 1, 2002; 70(5): 2344 - 2350. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. DeWitt, J. Y. Dong, H. S. Wiley, and D. A. Lauffenburger Quantitative analysis of the EGF receptor autocrine system reveals cryptic regulation of cell response by ligand capture J. Cell Sci., March 8, 2002; 114(12): 2301 - 2313. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Nguyen, S. H. Bride, A.-B. Badawy, R. M. Adam, J. Lin, A. Orsola, P. D. Guthrie, M. R. Freeman, and C. A. Peters Heparin-Binding EGF-Like Growth Factor Is Up-Regulated in the Obstructed Kidney in a Cell- and Region-Specific Manner and Acts to Inhibit Apoptosis Am. J. Pathol., March 1, 2000; 156(3): 889 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, P. Tzou, R. J. Hill, and P. W. Sternberg Structural Requirements for the Tissue-Specific and Tissue-General Functions of the Caenorhabditis elegans Epidermal Growth Factor LIN-3 Genetics, November 1, 1999; 153(3): 1257 - 1269. [Abstract] [Full Text] |
||||
![]() |
S. Clasper, S. Vekemans, M. Fiore, M. Plebanski, P. Wordsworth, G. David, and D. G. Jackson Inducible Expression of the Cell Surface Heparan Sulfate Proteoglycan Syndecan-2 (Fibroglycan) on Human Activated Macrophages Can Regulate Fibroblast Growth Factor Action J. Biol. Chem., August 20, 1999; 274(34): 24113 - 24123. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Paria, K Elenius, M Klagsbrun, and S. Dey Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation Development, January 5, 1999; 126(9): 1997 - 2005. [Abstract] [PDF] |
||||
![]() |
H. S. Wiley, M. F. Woolf, L. K. Opresko, P. M. Burke, B. Will, J. R. Morgan, and D. A. Lauffenburger Removal of the Membrane-anchoring Domain of Epidermal Growth Factor Leads to Intracrine Signaling and Disruption of Mammary Epithelial Cell Organization J. Cell Biol., November 30, 1998; 143(5): 1317 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Brown, K. S. Meise, G. D. Plowman, R. J. Coffey, and P. J. Dempsey Cell Surface Ectodomain Cleavage of Human Amphiregulin Precursor Is Sensitive to a Metalloprotease Inhibitor. RELEASE OF A PREDOMINANT N-GLYCOSYLATED 43-kDa SOLUBLE FORM J. Biol. Chem., July 3, 1998; 273(27): 17258 - 17268. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Miyoshi, S. Higashiyama, T. Nakagawa, N. Hayashi, and N. Taniguchi Membrane-anchored Heparin-binding Epidermal Growth Factor-like Growth Factor Acts as a Tumor Survival Factor in a Hepatoma Cell Line J. Biol. Chem., May 30, 1997; 272(22): 14349 - 14355. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Igura, S. Kawata, J.-i. Miyagawa, Y. Inui, S. Tamura, K. Fukuda, K. Isozaki, K. Yamamori, N. Taniguchi, S. Higashiyama, et al. Expression of Heparin-Binding Epidermal Growth Factor–Like Growth Factor in Neointimal Cells Induced by Balloon Injury in Rat Carotid Arteries Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1524 - 1531. [Abstract] [Full Text] |
||||
![]() |
A. Nakata, J.-i. Miyagawa, S. Yamashita, M. Nishida, R. Tamura, K. Yamamori, T. Nakamura, S. Nozaki, K. Kameda-Takemura, S. Kawata, et al. Localization of Heparin-Binding Epidermal Growth Factor–Like Growth Factor in Human Coronary Arteries: Possible Roles of HB-EGF in the Formation of Coronary Atherosclerosis Circulation, December 1, 1996; 94(11): 2778 - 2786. [Abstract] [Full Text] |
||||
![]() |
T. Nakagawa, S. Higashiyama, T. Mitamura, E. Mekada, and N. Taniguchi Amino-terminal Processing of Cell Surface Heparin-binding Epidermal Growth Factor-like Growth Factor Up-regulates Its Juxtacrine but Not Its Paracrine Growth Factor Activity J. Biol. Chem., November 29, 1996; 271(48): 30858 - 30863. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Riese II, E. D. Kim, K. Elenius, S. Buckley, M. Klagsbrun, G. D. Plowman, and D. F. Stern The Epidermal Growth Factor Receptor Couples Transforming Growth Factor-alpha , Heparin-binding Epidermal Growth Factor-like Factor, and Amphiregulin to Neu, ErbB-3, and ErbB-4 J. Biol. Chem., August 16, 1996; 271(33): 20047 - 20052. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Peifley, G. F. Alberts, D. K.W. Hsu, S.-L. Y. Feng, and J. A. Winkles Heparin-Binding Epidermal Growth Factor-Like Growth Factor Regulates Fibroblast Growth Factor-2 Expression in Aortic Smooth Muscle Cells Circ. Res., August 1, 1996; 79(2): 263 - 270. [Abstract] [Full Text] |
||||
![]() |
S. A. Thompson, A. Harris, D. Hoang, M. Ferrer, and G. R. Johnson COOH-terminal Extended Recombinant Amphiregulin with Bioactivity Comparable with Naturally Derived Growth Factor J. Biol. Chem., July 26, 1996; 271(30): 17927 - 17931. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Raab, K Kover, B. Paria, S. Dey, R. Ezzell, and M Klagsbrun Mouse preimplantation blastocysts adhere to cells expressing the transmembrane form of heparin-binding EGF-like growth factor Development, January 2, 1996; 122(2): 637 - 645. [Abstract] [PDF] |
||||
![]() |
Y. Shishido, K. D. Sharma, S. Higashiyama, M. Klagsbrun, and E. Mekada Heparin-like Molecules on the Cell Surface Potentiate Binding of Diphtheria Toxin to the Diphtheria Toxin Receptor/Membrane-anchored Heparin-binding Epidermal Growth Factor-like Growth Factor J. Biol. Chem., December 8, 1995; 270(49): 29578 - 29585. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fukuda, Y. Inui, S. Kawata, S. Higashiyama, Y. Matsuda, Y. Maeda, T. Igura, S. Yoshida, N. Taniguchi, and Y. Matsuzawa Increased Mitogenic Response to Heparin-Binding Epidermal Growth Factor–like Growth Factor in Vascular Smooth Muscle Cells of Diabetic Rats Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1680 - 1687. [Abstract] [Full Text] |
||||
![]() |
X. Chen, G. Raab, U. Deutsch, J. Zhang, R. M. Ezzell, and M. Klagsbrun Induction of Heparin-binding EGF-like Growth Factor Expression during Myogenesis J. Biol. Chem., August 4, 1995; 270(31): 18285 - 18294. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Lu, S. Hara, L. W.-I. Wong, M. D. Jones, V. Katta, G. Trail, A. Zou, D. Brankow, S. Cole, S. Hu, et al. Post-translational Processing of Membrane-associated neu Differentiation Factor Proisoforms Expressed in Mammalian Cells J. Biol. Chem., March 3, 1995; 270(9): 4775 - 4783. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mitamura, S. Higashiyama, N. Taniguchi, M. Klagsbrun, and E. Mekada Diphtheria Toxin Binds to the Epidermal Growth Factor (EGF)-like Domain of Human Heparin-binding EGF-like Growth Factor/Diphtheria Toxin Receptor and Inhibits Specifically Its Mitogenic Activity J. Biol. Chem., January 20, 1995; 270(3): 1015 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mesri, M Ono, R. Kreitman, M Klagsbrun, and I Pastan The heparin-binding domain of heparin-binding EGF-like growth factor can target Pseudomonas exotoxin to kill cells exclusively through heparan sulfate proteoglycans J. Cell Sci., January 9, 1994; 107(9): 2599 - 2608. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |